In addressing a mountain of price-fixing claims in the United States, Teva has shown a preference for dealing with charges on a state-by-state basis.
On Friday, when Teva agreed to settle with Georgia for $3.346 million, the company checked a third state off its price-fixing litigation list and then crowed about the success of its strategy.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,